Nt. (B) Mice were immunized five times i.p. with the same envelope antigens and Ribi adjuvant. Splenocytes were collected two weeks after the final boost and tested for envelope-specific proliferation by H-thymidine incorporation. Proliferation in the presence of antigen (3 μg/ml) or medium alone was measured after a 5-day culture. The stimulation indices of individual mice and the mean values for each group (horizontal bars) are shown. Statistical analyses were done using one-way ANOVA with Bonferroni's multiple comparison test.<p><b>Copyright information:</b></p><p>Taken from "Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response"</p><p>http://www.infectagentscancer...
<p>Two weeks after the last immunization with HIVBr27 or empty pVAX1, pooled spleen cells from 6 BAL...
A murine monoclonal antibody (MAb F-91-55) raised against the complex of soluble CD4 and human immun...
<div><p>The CD4 binding site (CD4BS) of the HIV-1 envelope glycoprotein (Env) contains epitopes for ...
MAb (1418), along with Ribi adjuvant. Each animal received 3 μg of gp120 and 10 μg of mAb. Control m...
Bs mAb 654 or anti-C5 mAb 450 (10 μg/ml each). B) Proliferation of clone T1 was tested in response t...
The wells and gp120-specific IgG or IgM were detected with alkaline phosphatase-conjugated rabbit Ab...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. (B) The ...
Conserved regions on the HIV-1 envelope spike are important for vaccine design due to their vulnerab...
<p>BALB/c mice (n = 5 per group) received 2 doses with 10 or 1μg of gp140 via s.c in the presence of...
<p>Groups of C57BL/6 mice were immunized with gp120 protein (20 μg/ml)-pulsed, transduced BM-derived...
Prime-boost vaccination regimes have shown promise for obtaining protective immunity to HIV. Poorly ...
<p>BALB/c mice were immunized once with DNA encoding the indicated vaccine constructs. DNA (25 µg DN...
Prime-boost vaccination regimes have shown promise for obtaining protective immunity to HIV. Poorly ...
<p>Viral replication assessed by determining HIV-1 RNA (A), p24 (B), Gag-p24<sup>+</sup> thymocytes ...
<p>(<b>A</b>) Description of the different vectors employed in the DNA/MVA immunization schemes appl...
<p>Two weeks after the last immunization with HIVBr27 or empty pVAX1, pooled spleen cells from 6 BAL...
A murine monoclonal antibody (MAb F-91-55) raised against the complex of soluble CD4 and human immun...
<div><p>The CD4 binding site (CD4BS) of the HIV-1 envelope glycoprotein (Env) contains epitopes for ...
MAb (1418), along with Ribi adjuvant. Each animal received 3 μg of gp120 and 10 μg of mAb. Control m...
Bs mAb 654 or anti-C5 mAb 450 (10 μg/ml each). B) Proliferation of clone T1 was tested in response t...
The wells and gp120-specific IgG or IgM were detected with alkaline phosphatase-conjugated rabbit Ab...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. (B) The ...
Conserved regions on the HIV-1 envelope spike are important for vaccine design due to their vulnerab...
<p>BALB/c mice (n = 5 per group) received 2 doses with 10 or 1μg of gp140 via s.c in the presence of...
<p>Groups of C57BL/6 mice were immunized with gp120 protein (20 μg/ml)-pulsed, transduced BM-derived...
Prime-boost vaccination regimes have shown promise for obtaining protective immunity to HIV. Poorly ...
<p>BALB/c mice were immunized once with DNA encoding the indicated vaccine constructs. DNA (25 µg DN...
Prime-boost vaccination regimes have shown promise for obtaining protective immunity to HIV. Poorly ...
<p>Viral replication assessed by determining HIV-1 RNA (A), p24 (B), Gag-p24<sup>+</sup> thymocytes ...
<p>(<b>A</b>) Description of the different vectors employed in the DNA/MVA immunization schemes appl...
<p>Two weeks after the last immunization with HIVBr27 or empty pVAX1, pooled spleen cells from 6 BAL...
A murine monoclonal antibody (MAb F-91-55) raised against the complex of soluble CD4 and human immun...
<div><p>The CD4 binding site (CD4BS) of the HIV-1 envelope glycoprotein (Env) contains epitopes for ...